Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Eisai claims novel polycyclic compounds against beta-amyloid load

March 26, 2009

Abilify oral solution 0.1% to be launched in Japan in April

March 26, 2009

Novel pyrazoloquinoline and pyrazolonaphthyridine derivatives claimed by Novartis

March 26, 2009

Novel GABA(A) modulator shows antinociceptive activity in vivo

March 26, 2009

Lilly presents novel gamma-secretase inhibitors

March 25, 2009

Epiphany Biosciences to file IND to study valomaciclovir adjunctive therapy in MS

March 25, 2009

Novel histamine H3 receptor antagonists claimed in AstraZeneca patent

March 25, 2009

Oxcarbazepine reduces pain in Parkinson's disease patients

March 25, 2009

Roche presents novel pyrrolodine aryl-ether compounds

March 24, 2009

Exalgo extended-release meets primary efficacy endpoint in phase III trial

March 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....